Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test von Drake, AS, Weinstock-Guttman, B., Morrow, SA, Hojnacki, D., Munschauer, FE, Benedict, RHB

Volltext

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire von Benedict, RHB, Duquin, JA, Jurgensen, S, Rudick, RA, Feitcher, J, Munschauer, FE, Panzara, MA, Weinstock-Guttman, B

Volltext

Rapid disease course in African Americans with multiple sclerosis von KISTER, I, CHAMOT, E, JUBELT, B, KRUPP, L, LENIHAN, M, LUBLIN, F, MIHAI, C, MILLER, A, MUNSCHAUER, F. E, PEREL, A. B, TETER, B. E, WEINSTOCK-GUTTMAN, B, BACON, J. H, ZIVADINOV, R, HERBERT, J, NIEWCZYK, P. M, DE GUZMAN, R. A, APATOFF, B, COYLE, P, GOODMAN, A. D, GOTTESMAN, M, GRANGER, C

Volltext

Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis von Morrow, SA, Weinstock-Guttman, B, Munschauer, FE, Hojnacki, D, Benedict, RHB

Volltext

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS von Strober, L, Englert, J, Munschauer, F, Weinstock-Guttman, B, Rao, S, Benedict, RHB

Volltext

Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy von Benedict, R H B, Ramasamy, D, Munschauer, F, Weinstock-Guttman, B, Zivadinov, R

Volltext

Neutralising antibodies to interferon beta during the treatment of multiple sclerosis von Giovannoni, G, Munschauer, F E, Deisenhammer, F

Volltext

Interpreting patient/informant discrepancies of reported cognitive symptoms in MS von CARONE, D.A., BENEDICT, R.H.B., III, F.E. MUNSCHAUER, FISHMAN, I., WEINSTOCK-GUTTMAN, B.

Volltext

Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test von Parmenter, B A, Weinstock-Guttman, B, Garg, N, Munschauer, F, Benedict, R HB

Volltext

Increased tissue damage and lesion volumes in African Americans with multiple sclerosis von WEINSTOCK-GUTTMAN, B, RAMANATHAN, M, HASHMI, K, ABDELRAHMAN, N, HOJNACKI, D, DWYER, M. G, HUSSEIN, S, BERGSLAND, N, MUNSCHAUER, F. E, ZIVADINOV, R

Volltext

Gender-related differences in MS: a study of conventional and nonconventional MRI measures von Antulov, R, Weinstock-Guttman, B, Cox, JL, Hussein, S, Durfee, J, Caiola, C, Dwyer, MG, Bergsland, N, Abdelrahman, N, Stosic, M, Hojnacki, D, Munschauer, FE, Miletic, D, Zivadinov, R

Volltext

A longitudinal study of brain atrophy in relapsing multiple sclerosis von SIMON, J. H, JACOBS, L. D, SIMONIAN, N, LAJAUNIE, M, MILLER, D. E, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, MUNSCHAUER, F. E, BROWNSCHEIDLE, C. M, CAMPION, M. K, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GOODKIN, D. E

Volltext

Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis von Brass, S D, Benedict, R HB, Weinstock-Guttman, B, Munschauer, F, Bakshi, R

Volltext

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire von Benedict, R HB, Munschauer, F, Linn, R, Miller, C, Murphy, E, Foley, F, Jacobs, L

Volltext

Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients von Rudick, RA, Kappos, L, Kinkel, R, Clanet, M, Phillips, JT, Herndon, RM, Sandrock, AW, Munschauer, FE

Volltext

Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the Proceedings of an International Consensus Conference von Hartung, H.-P., Munschauer III, F., Schellekens, H.

Volltext

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium von WEINSTOCK-GUTTMAN, B, JACOBS, L. D, GOTTESMAN, M. H, HERBERT, J, HOLUB, R, LAVA, N. S, LENIHAN, M, LUSINS, J, MIHAI, C, MILLER, A. E, PEREL, A. B, SNYDER, D. H, BROWNSCHEIDLE, C. M, BAKSHI, R, GRANGER, C. V, GREENBERG, S. J, JUBELT, B, KRUPP, L, MUNSCHAUER, F. E, RUBIN, D, SCHWID, S, SMIROLDO, J, BAIER, M, REA, D. F, APATOFF, B. R, BLITZ, K. M, COYLE, P. K, FRONTERA, A. T, GOODMAN, A. D

Volltext

Soluble receptor for advanced glycation end products in multiple sclerosis: A potential marker of disease severity von Sternberg, Z, Weinstock-Guttman, B, Hojnacki, D, Zamboni, P, Zivadinov, R, Chadha, K, Lieberman, A, Kazim, L, Drake, A, Rocco, P, Grazioli, E, Munschauer, F

Volltext

Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients von Benedict, R. H. B., Munschauer, F., Zarevics, P., Erlanger, D., Rowe, V., Feaster, T., Carpenter, R. L.

Volltext

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis von RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Volltext